Mobile Menu Toggle

CLASSIC MARVEL FIG COLL MAG SPECIAL MAN THING

EAGLEMOSS PUBLICATIONS LTD
NOV084370
"Whatever knows fear, burns at the touch of The Man-Thing!" The muck-encrusted monstrosity known as Man-Thing first shambled from the pages of Marvel Comics' Savage Tales Volume 1, #1, and into the annals of comic book history as one of the most startling and misunderstood slime creatures ever to surface from Marvel's staple of horrifying characters. The result of a radical experiment gone horribly awry, this mindless mockery of a man was once Ted Sallis, a biochemist stationed in the Everglades who developed a "miracle drug" in an attempt at recreating the "super-soldier serum" that created Captain America. Victim of betrayal and hunted down by agents from A.I.M. (Advanced Idea Mechanics) who coveted his formula and research, Sallis flees, injecting himself with the only existing sample of the serum - mere moments before his car crashes into the fetid swamps in a fiery blaze! Ted Sallis should have died that day... but, what emerged from the swamp through the amalgam of his formula and the mysterious, elemental forces extant in the murky bog was some-thing beyond human comprehension...a Man-Thing! Packed with detailed history, background, and exclusive images and interviews, this special, slipcased edition of Classic Marvel Figurine Collection Magazine features a hand-painted, sculpted, lead Man-Thing figurine and a double-sided poster.
In Shops: Jan 28, 2009
SRP: $20.00
View All Items In This Series
Follow Us Facebook Icon Twitter Icon Instagram Icon YouTube Icon Rss Feed Email
Search for a Comic Shop
Last Chance Pre-Orders for November 25th Last Chance Pre-Orders for November 25th

It's your last chance to guarantee a pre-order for these comics, graphic novels, and toys at your local comic shop. Make sure to get your orders in by November 25th!


Cookies
We use cookies to understand how you use our site and to improve your experience. To manage our use of cookies click Cookie Policy.
By clicking 'Accept & Continue' or closing this banner, you accept our use of cookies.
}